Literature DB >> 33555940

Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments.

Ian F Tannock1, Mark J Ratain2, Daniel A Goldstein3, Allen S Lichter4, Gary L Rosner5, Leonard B Saltz6.   

Abstract

Year:  2021        PMID： 33555940     DOI： 10.1200/JCO.20.02768

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  When Less May Be Enough: Dose Selection Strategies for Immune Checkpoint Inhibitors Focusing on AntiPD-(L)1 Agents.

Authors:  Daniel V Araujo; Bruno Uchoa; Juan José Soto-Castillo; Larissa L Furlan; Marc Oliva
Journal:  Target Oncol       Date:  2022-06-10       Impact factor: 4.864

Review 2.  Priorities for cancer research in low- and middle-income countries: a global perspective.

Authors:  C S Pramesh; Rajendra A Badwe; Nirmala Bhoo-Pathy; Christopher M Booth; Girish Chinnaswamy; Anna J Dare; Victor Piana de Andrade; David J Hunter; Satish Gopal; Mary Gospodarowicz; Sanjeeva Gunasekera; Andre Ilbawi; Sharon Kapambwe; Peter Kingham; Tezer Kutluk; Nirmal Lamichhane; Miriam Mutebi; Jackson Orem; Groesbeck Parham; Priya Ranganathan; Manju Sengar; Richard Sullivan; Soumya Swaminathan; Ian F Tannock; Vivek Tomar; Verna Vanderpuye; Cherian Varghese; Elisabete Weiderpass
Journal:  Nat Med       Date:  2022-04-19       Impact factor: 87.241

3.  Clinical research in oncology: in memory of Professor Gordon McVie.

Authors:  Ian F Tannock
Journal:  Ecancermedicalscience       Date:  2022-01-13

4.  Challenges in Access to New Therapeutic Agents: Marginalized Patients With Cancer in Pakistan and the Need for New Guidelines.

Authors:  Zeba Aziz; Hafsa Naseer; Anjum Altaf
Journal:  JCO Glob Oncol       Date:  2022-02

5.  Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings.

Authors:  Po-Hung Hsieh; Alec J Kacew; Marie Dreyer; Anthony V Serritella; Randall W Knoebel; Garth W Strohbehn; Mark J Ratain
Journal:  NPJ Breast Cancer       Date:  2022-03-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.